0,978  0,001  Antihypercholesterolemic
0,975  0,001  Chemopreventive
0,968  0,002  Chemoprotective
0,960  0,001  Cholesterol antagonist
0,941  0,002  Proliferative diseases treatment
0,931  0,003  TNF expression inhibitor
0,927  0,004  Transcription factor NF kappa B inhibitor
0,900  0,002  Sulfotransferase substrate
0,884  0,004  Teratogen
0,858  0,003  Sensitization
0,858  0,005  Embryotoxic
0,846  0,005  Caspase 9 stimulant
0,841  0,007  CYP3A4 substrate
0,833  0,003  CTGF expression inhibitor
0,824  0,000  Cholesterol synthesis inhibitor
0,818  0,004  CYP2C19 substrate
0,812  0,002  UGT1A4 substrate
0,813  0,004  NOS3 expression inhibitor
0,817  0,015  Apoptosis agonist
0,800  0,002  Amylase inhibitor
0,797  0,003  UGT1A3 substrate
0,799  0,007  Carcinogenic
0,789  0,003  Anesthetic
0,788  0,002  UGT2B1 substrate
0,799  0,015  Antiinflammatory
0,789  0,006  Respiratory analeptic
0,785  0,003  Hair growth stimulant
0,763  0,004  UGT1A1 substrate
0,758  0,001  UGT2B4 substrate
0,757  0,009  CYP2C9 substrate
0,734  0,002  Antihyperlipoproteinemic
0,714  0,003  Antipruritic, allergic
0,706  0,005  UGT1A6 substrate
0,698  0,007  Bone diseases treatment
0,695  0,005  Hepatic disorders treatment
0,688  0,007  NOS2 expression inhibitor
0,691  0,022  Antineoplastic (breast cancer)
0,646  0,004  Melanin inhibitor
0,650  0,008  Antiosteoporotic
0,646  0,008  Lipoprotein disorders treatment
0,630  0,002  UGT2B7 substrate
0,636  0,014  Prostate cancer treatment
0,624  0,005  Amyotrophic lateral sclerosis treatment
0,617  0,008  Antipyretic
0,621  0,012  Analeptic
0,611  0,003  Anticataract
0,613  0,008  Apoptosis antagonist
0,608  0,011  Cytotoxic
0,597  0,002  Interferon gamma antagonist
0,594  0,007  UDP-glucuronosyltransferase substrate
0,607  0,029  Antineoplastic (lung cancer)
0,589  0,012  Antioxidant
0,581  0,005  Prostatic (benign) hyperplasia treatment
0,579  0,005  Anesthetic general
0,581  0,017  Antineoplastic (ovarian cancer)
0,565  0,002  Choleretic
0,575  0,028  Antileukemic
0,548  0,014  Antipsoriatic
0,531  0,005  Phospholipase C inhibitor
0,542  0,016  AR expression inhibitor
0,526  0,003  LDLR expression enhancer
0,531  0,012  Hypoxia-inducible factor 1 alpha inhibitor
0,526  0,014  Nitric oxide antagonist
0,514  0,003  Sodium/bile acid cotransporter inhibitor
0,532  0,025  Immunosuppressant
0,511  0,004  Protein kinase stimulant
0,513  0,011  Hypolipemic
0,522  0,021  Antineoplastic (melanoma)
0,508  0,009  Antineoplastic (liver cancer)
0,514  0,015  Free radical scavenger
0,500  0,005  Prostate disorders treatment
0,493  0,004  Androgen antagonist
0,493  0,005  Antiacne
0,507  0,021  Antineoplastic (cervical cancer)
0,484  0,003  Antipruritic, non-allergic
0,502  0,022  Radioprotector
0,476  0,006  Abortion inducer
0,481  0,023  Antineoplastic (pancreatic cancer)
0,460  0,004  Autism spectrum disorders treatment
0,490  0,034  Atherosclerosis treatment
0,456  0,001  5-Alpha-reductase 2 inhibitor
0,458  0,009  Hepatoprotectant
0,449  0,002  5-Alpha-reductase inhibitor
0,497  0,051  Antidiabetic
0,497  0,051  Cyclophilin D inhibitor
0,475  0,032  Immunostimulant
0,465  0,029  Antifungal
0,439  0,005  DNA polymerase I inhibitor
0,441  0,010  Contraceptive
0,444  0,016  Antineoplastic (renal cancer)
0,432  0,013  P-glycoprotein inhibitor
0,425  0,007  Lipocortins synthesis antagonist
0,439  0,026  ICAM1 expression inhibitor
0,441  0,029  Antineoplastic (glioma)
0,427  0,020  Interleukin 2 agonist
0,442  0,035  CYP2D6 substrate
0,430  0,027  Antineoplastic (multiple myeloma)
0,421  0,019  Antihypertriglyceridemic
0,406  0,004  Farnesoid X receptor antagonist
0,425  0,033  Antineoplastic (brain cancer)
0,404  0,014  Muscle relaxant
0,425  0,037  Caspase 3 stimulant
0,389  0,005  Antiinfertility, female
0,395  0,012  Platelet adhesion inhibitor
0,399  0,019  Sedative
0,439  0,061  Antibacterial
0,405  0,035  Metabolic disease treatment
0,381  0,014  Skin whitener
0,367  0,003  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,385  0,021  Interleukin agonist
0,373  0,012  VCAM1 expression inhibitor
0,387  0,031  Antiamyloidogenic
0,360  0,006  UGT2B9 substrate
0,385  0,030  Antineoplastic (glioblastoma multiforme)
0,406  0,052  Antineoplastic (colorectal cancer)
0,361  0,010  NOS3 expression enhancer
0,350  0,002  Anticholelithogenic
0,380  0,034  Antiprotozoal (Leishmania)
0,382  0,039  UGT1A9 substrate
0,353  0,011  Liver fibrosis treatment
0,390  0,052  Antineoplastic (colon cancer)
0,370  0,033  Hypoglycemic
0,364  0,028  Antineoplastic (endocrine cancer)
0,355  0,031  Angiogenesis stimulant
0,331  0,008  Antifungal enhancer
0,388  0,069  CYP2C19 inhibitor
0,333  0,015  Monophenol monooxygenase inhibitor
0,349  0,040  Antihypoxic
0,310  0,004  Pregnane X receptor agonist
0,307  0,002  5-Alpha-reductase 1 inhibitor
0,344  0,039  Antineoplastic (lymphoma)
0,304  0,003  Bile acid receptor antagonist
0,298  0,003  Liver X receptor alpha agonist
0,317  0,026  Antiviral (Influenza)
0,334  0,047  Antineoplastic (non-small cell lung cancer)
0,329  0,043  Cardiodepressant
0,325  0,042  Myocardial infarction treatment
0,284  0,003  Glycine receptor agonist
0,287  0,006  Contraceptive female
0,296  0,018  UGT2B15 substrate
0,321  0,046  Tumour necrosis factor alpha release inhibitor
0,324  0,049  DNA damaging
0,290  0,018  Antiviral (Influenza A)
0,329  0,059  Antiepileptic
0,276  0,008  Retinoprotector
0,274  0,008  UGT2B10 substrate
0,274  0,008  Alcohol dehydrogenase substrate
0,265  0,004  CDC25A inhibitor
0,320  0,062  Cardioprotectant
0,279  0,022  Lipid peroxidase inhibitor
0,261  0,004  Actinic keratosis treatment
0,304  0,048  Vascular (periferal) disease treatment
0,304  0,050  Antidiabetic symptomatic
0,293  0,045  Antiulcerative
0,253  0,005  Arachidonic acid antagonist
0,286  0,039  Antineoplastic enhancer
0,272  0,025  Protein-tyrosine phosphatase inhibitor
0,311  0,066  Spasmolytic
0,256  0,016  Protein-tyrosine phosphatase 1B inhibitor
0,324  0,085  Inflammatory Bowel disease treatment
0,246  0,010  Microtubule formation inhibitor
0,260  0,030  Antiviral (Herpes)
0,352  0,126  Alzheimer's disease treatment
0,234  0,013  Liver cirrhosis treatment
0,221  0,008  ABCA1 expression enhancer
0,233  0,020  Psychosexual dysfunction treatment
0,228  0,015  Expectorant
0,214  0,009  Vanilloid 1 agonist
0,213  0,009  HIV-1 integrase (Strand Transfer) inhibitor
0,228  0,025  Antidiarrheal
0,231  0,030  Skin irritative effect
0,219  0,020  Neurotrophic factor
0,258  0,061  Antineoplastic (sarcoma)
0,251  0,057  Amyloid beta aggregation inhibitor
0,282  0,092  Immunomodulator
0,194  0,005  UGT2B11 substrate
0,263  0,082  Antidiabetic (type 2)
0,241  0,060  Antiviral (HIV)
0,260  0,082  Renal disease treatment
0,244  0,070  Cytostatic
0,191  0,019  Growth stimulant
0,273  0,103  Antihypertensive
0,184  0,014  AMP-activated protein kinase stimulant
0,178  0,010  Aromatase inhibitor
0,259  0,092  CYP1A2 substrate
0,224  0,060  Wound healing agent
0,174  0,011  Toll-Like receptor 4 antagonist
0,171  0,009  Anabolic
0,277  0,116  Calcium channel activator
0,171  0,010  Postmenopausal disorders treatment
0,177  0,016  Estrogen antagonist
0,184  0,024  Endometrios treatment
0,176  0,015  Hedgehog signaling inhibitor
0,158  0,002  Cholesterol absorption inhibitor
0,160  0,004  Na+ K+ transporting ATPase inhibitor
0,217  0,062  Neurotrophic factor enhancer
0,224  0,071  Antimitotic
0,163  0,010  Estrogen agonist
0,153  0,004  RNA-directed RNA polymerase stimulant
0,205  0,056  Diabetic retinopathy treatment
0,203  0,056  Diabetic nephropathy treatment
0,178  0,031  Antieczematic
0,190  0,049  Antineoplastic (bone cancer)
0,268  0,130  Stroke treatment
0,148  0,016  Contraceptive male
0,199  0,068  Mutagenic
0,138  0,008  CDC25B inhibitor
0,137  0,008  Androgen agonist
0,164  0,036  Antihemorrhagic
0,194  0,069  Growth factor agonist
0,134  0,011  Hyperparathyroidism treatment
0,137  0,014  Estrogen receptor alpha antagonist
0,183  0,061  Antimutagenic
0,178  0,056  Interleukin 6 antagonist
0,181  0,060  Toxic, respiratory center
0,140  0,018  Inducible nitric-oxide synthase inhibitor
0,168  0,047  Bone formation stimulant
0,124  0,005  Liver X receptor agonist
0,241  0,127  Antineoplastic (osteosarcoma)
0,165  0,054  Skeletal muscle relaxant
0,113  0,004  Farnesoid X receptor agonist
0,126  0,018  HIV-1 integrase (3'-Processing) inhibitor
0,116  0,008  Hypercalcemia treatment
0,141  0,035  HDL-cholesterol increasing
0,151  0,048  Anesthetic local
0,126  0,026  SULT1E1 substrate
0,118  0,019  Glycine receptor antagonist
0,125  0,027  Estrogen receptor beta antagonist
0,131  0,035  Antineoplastic antibiotic
0,156  0,061  Antidiabetic (type 1)
0,177  0,082  Antihelmintic
0,100  0,005  Lipocortins synthesis agonist
0,183  0,092  Insulin sensitizer
0,096  0,009  Estrogen receptor alpha agonist
0,226  0,140  Antiallergic
0,155  0,070  Insulin secretagoues
0,114  0,031  Ornithine decarboxylase inhibitor
0,083  0,002  Hedgehog signaling activator
0,137  0,060  Cyclooxygenase 3 inhibitor
0,086  0,009  Glucose-6-phosphate translocase inhibitor
0,115  0,039  Antineoplastic alkaloid
0,139  0,064  Tubulin antagonist
0,099  0,031  Keratolytic
0,100  0,033  Vanilloid agonist
0,081  0,014  Estrogen receptor beta agonist
0,095  0,029  SULT1A2 substrate
0,093  0,028  Cushing's syndrome treatment
0,137  0,074  Antineoplastic (squamous cell carcinoma)
0,065  0,004  Vitamin D receptor antagonist
0,143  0,083  Diuretic
0,064  0,006  Glucose-6-phosphate dehydrogenase inhibitor
0,115  0,058  Chelator
0,079  0,023  Nitric oxide donor
0,066  0,009  Glucocorticoid antagonist
0,122  0,066  Alkylator
0,075  0,020  Heme oxygenase stimulant
0,135  0,081  Antineoplastic (carcinoma)
0,106  0,053  Antineoplastic, alkylator
0,122  0,069  Antiviral (Hepatitis B)
0,097  0,045  ATPase (Vacuolar H+) inhibitor
0,106  0,055  Dementia treatment
0,103  0,054  Vascular dementia treatment
0,164  0,116  Antiparasitic
0,212  0,163  Antithrombotic
0,059  0,012  Parathyroid hormone antagonist
0,174  0,128  Vasodilator
0,176  0,130  Age-related macular degeneration treatment
0,186  0,140  Antituberculosic
0,052  0,006  HMG CoA reductase inhibitor
0,067  0,025  Postcoital contraceptive
0,090  0,051  Transcription factor NF kappa B stimulant
0,049  0,011  Liver X receptor beta agonist
0,223  0,184  Antiobesity
0,158  0,121  EphB2 antagonist
0,079  0,043  Antitreponemal
0,060  0,024  Heparanase inhibitor
0,041  0,007  CYP24 inhibitor
0,164  0,130  Antineoplastic (lymphocytic leukemia)
0,132  0,098  Phospholipase A2 inhibitor
0,055  0,021  Microtubule stabilization
0,068  0,035  Beta tubulin antagonist
0,054  0,023  Estradiol 17 beta-dehydrogenase inhibitor
0,033  0,003  Vitamin D receptor agonist
0,105  0,076  Interleukin 1b antagonist
0,189  0,161  Antimycobacterial
0,107  0,079  Proteasome inhibitor
0,101  0,077  Mucolytic
0,030  0,007  Corticosteroid-like
0,051  0,029  Mineralocorticoid receptor antagonist
0,173  0,156  Huntington's disease treatment
0,028  0,011  Estrone sulfatase inhibitor
0,030  0,015  1,3-Beta-glucan synthase inhibitor
0,169  0,155  Antihypotensive
0,089  0,078  Glutathione S-transferase substrate
0,015  0,005  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,050  0,040  Alpha tubulin antagonist
0,040  0,031  Hypogonadism treatment
0,020  0,011  Apical sodium codependent bile acid transporter inhibitor
0,055  0,047  Botulinum neurotoxin type A inhibitor
0,065  0,057  HIV-1 integrase inhibitor
0,018  0,012  Progesterone agonist
0,094  0,088  SULT1A1 substrate
0,035  0,030  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,056  0,053  Transcription factor AP-1 inhibitor
0,117  0,114  Thrombolytic
0,012  0,010  Glucocorticoid agonist
0,210  0,208  Antiprotozoal
0,004  0,003  Vitamin D-like
0,121  0,120  Acute respiratory distress syndrome (ARDS) treatment
0,015  0,015  Ileal bile acid transport inhibitor

